SEC
SlamSEC
Search
Browse
Earnings
Rafael Holdings, Inc.
NYSE:
RFL
Pharmaceutical Preparations
·
NEWARK, NJ
Overview
All Filings
Sum Fin
Credit
Insiders
Governance
Overview
All Filings
Sum Fin
Credit
Insiders
Governance
Summary Financials
Revenue
$30,000
FY 2025
Adj. EBITDA
-$102.6M
-341850.0% margin
FY 2025
Net Income
-$34.4M
-114700.0% margin
FY 2025
EPS (Diluted)
-$1.45
FY 2025
Stock Price
$1.46
-2.7%
2026-03-12
52W Range
$1.12 – $3.19
P/E Ratio
-1.0x
Market Cap
$146
Cash
$2.7M
FY 2025
Total Debt
$2.6M
FY 2020
Net Cash
$26,000
FY 2020
Enterprise Value
-$25,854
Debt / EBITDA
0.0x
FY 2025
EV / EBITDA
0.0x
Employees
—